haku: @journal_id 1399 / yhteensä: 95
viite: 17 / 95
| Tekijä: | Olson, M. |
| Otsikko: | Regulatory reform and bureaucratic responsiveness to firms: the impact of user fees in the FDA |
| Lehti: | Journal of Economics and Management Strategy
2000 : FALL, VOL. 9:3, p. 363-396 |
| Asiasana: | MANAGEMENT ECONOMICS USER CHARGES |
| Kieli: | eng |
| Tiivistelmä: | This paper examines the impact of user fees on the speed of new-drug review and on the responsiveness of FDA reviewers to pharamceutical firms. User fees are expected to alter FDA behavior and responsiveness to pharamceutical firms because they give regulators a financial incentive to process more new-drug applications and because they convey information to regulators that may reduce type I error. The analysis examines the variation in FDA review times for new drugs approved between 1990 and 1995 as a function of differences that exist among firms and drugs. |
SCIMA